Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

This publication has 37 references indexed in Scilit:

• Enzyme Replacement Therapy in Feline Mucopolysaccharidosis I
  Molecular Genetics and Metabolism, 2001
• Enzyme-Replacement Therapy in Mucopolysaccharidosis I
  New England Journal of Medicine, 2001
• The human gene mutation database
  Trends in Genetics, 1997
• Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis I
  Biochemical and Molecular Medicine, 1996
• Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implications
  Human Mutation, 1995
• Enzyme replacement in a canine model of Hurler syndrome.
  Proceedings of the National Academy of Sciences, 1994
• REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATION
  The Lancet, 1981
• Recognition and receptor-mediated uptake of a lysosomal enzyme, α-l-iduronidase, by cultured human fibroblasts
  Cell, 1977
• The Defect in the Hurler and Scheie Syndromes: Deficiency of α-L-Iduronidase
  Proceedings of the National Academy of Sciences, 1972
• THE DEFECT IN HURLER AND HUNTER SYNDROMES, II. DEFICIENCY OF SPECIFIC FACTORS INVOLVED IN MUCOPOLYSACCHARIDE DEGRADATION
  Proceedings of the National Academy of Sciences, 1969